You are here

News

FDA gives green light to MINT technology to treat colonic lesions

Building on the license they received from Cornell in 2014, Lumendi has secured FDA clearance for DiLumen (the MINT technology formally known as ESP).

The Dilumen is an endoscopic accessory, which is intended to help with positioning an endoscope in the large intestine and includes a single-use, soft flexible sheath that fits over standard and small-diameter colonoscopes. It utilizes two balloons – one behind the bending section of the colonoscope and the other in front of the tip – to...

Read More

Sphere paper wins award

Research carried out in collaboration between MINT and University College London has won a prestigious award from the Journal of Cardiovascular Engineering Technologies (CVET).

"The 'Sphere': A Dedicated Bifurcation Aneurysm Flow-Diverter Device" was the most downloaded article published in...

Read More

Cornell Engineering Partners with MINT through Kessler Fellowship

This summer, MINT is excited to partner with Jonlin Chen, an undergraduate at Cornell University. Jonlin is currently a junior studying biological engineering and a Cornell Engineering Kessler Fellow.


The Kessler Fellows Program offers fifteen select junior Cornell Engineering students a unique year-long experience comprised of an entrepreneurism class followed by a summer placement in any...

Read More

ESP Device continues development at Lumendi, Ltd

MINT and Lumendi have been incredibly successful thus far in their collaboration on the Endolumenal Surgical Platform (ESP). ESP is a disposable device that fits over an endoscope to provide improved visualization inside the colon. The Lumendi team recently hired 4 new team members for Marketing, Regulatory Affairs and Quality Assurance, Research and Development, and Medical Affairs. The company plans to file the ESP device with the FDA in late 2016, and hopes to have FDA...

Read More

MINT Names New Research Fellow

The MINT program is excited to announce that Dr. Hisashi Hara will be joining the MINT team as a Research Fellow. Dr. Hara brings years of clinical expertise in gastrointestinal surgery to MINT. Before joining the MINT team, Dr. Hara worked on the development of medical devices to detect gastric cancer metastases as well as on drug development clinical trials for oesophageal cancer. Dr. Hara was formerly a Resident of Surgery at Osaka...

Read More

MINT Program Appoints Two New Biomedical Engineers

The MINT program is growing and recently appointed Andrew Harvey and Russell Corwin as Biomedical Engineers.

Harvey and Corwin will work across the full spectrum of MINT projects. 

Prior to joining MINT, Harvey worked as a Biomedical Design Engineer for Nuvasive, Inc in San Diego, California where he developed spinal procedures, focusing on minimally invasive procedures, specifically the Transforaminal Lumbar Interbody Fusion (TLIF) and eXtreme Lateral Interbody Fusion (XLIF)....

Read More

Weill Cornell Medical College and NewYork-Presbyterian Hospital License Technology to Lumendi, Ltd.

MINT has teamed up with entrepreneurs and investors to establish Lumendi, a new start-up company dedicated to producing next-generation endoscopic tools that make complex gastrointestinal surgeries safer and less expensive while also improving patient outcomes.

The agreement between Weill Cornell and Lumendi will advance the development of the Endolumenal Surgical Platform (ESP), a new disposable device which fits over a standard endoscope like a sleeve and provides increased stability...

Read More

MINT Names New Director of Operations and Strategy

The MINT program has appointed Matthew Baird Director of Operations and Strategy. Baird joins us from the Center for Advanced Digestive Care (CADC) at NewYork-Presbyterian Hospital (NYP) where he had responsibilities for matters relating to strategy, operations and financial management.

Prior to joining NYP in 2012, Baird worked in a range of healthcare roles in the United Kingdom, including strategic planning at Guy's and St Thomas' NHS Foundation Trust, financial management at NHS...

Read More

MINT Presents ESP Device at SAGES Annual Meeting 2015, Nashville TN

MINT is proud to announce the presentation of our novel ESP add-on device to improve stabilization and visualization through colonoscopy during the SAGES Annual Meeting 2015, Nashville TN. esp_poster_v2.pdf

ESP Technology Patent Issued in the United States

A new patent for our Endolumenal Surgical Platform (ESP) technology has issued today by The United States Patent and Trademark Office (USPTO).

ESP is a medical device developed by MINT that works in conjunction with current endoscopes to significantly enhance endoscopy and polypectomy, enabling endolumenal treatment of challenging polyps that were formerly referred to surgery. We estimate that in the US alone some 40,000 open surgeries for the removal of difficult polyps could be...

Read More

Fourth Sphere Technology Patent Issued in the United States

We are happy to announce an additional patent for our Spherical Aneurysm Device technology for the treatment of cerebral aneurysms patent has issued in The United States.

Sphere is an implantable spherical device made of memory metal.  It is delivered to a location opposite the neck of a cranial saccular aneurysm located at a bifurcation point in the neurovasculature.  The device will reduce blood flow into the aneurysm, decreasing the likelihood that the aneurysm will rupture, and...

Read More

Sphere Technology Patent Issued in the United States

We are excited to announce that a new patent for our Spherical Aneurysm Device technology for the treatment of cerebral aneurysms has issued in the United States.

The MINT team is developing a set of next-generation flow diverting devices to treat complex cerebral aneurysms located at vessel bifurcations.  The spherical shape of the devices enable clinicians to endovascularly treat a wide range of aneurysms, including aneurysms with challenging...

Read More

iMold Technology Patent Issued in the United States

MINT announces that a patent for our Injectable Mold (iMold) technology has been issued by the United States by The United States Patent and Trademark Office (USPTO). The patent, Nos. 8,932,326 B2, and titled “Method and apparatus for repairing vascular abnormalities and/or other body lumen abnormalities using an endoluminal approach and a flowable forming material” represents the first patent issued for a family of applications focused...

Read More

Article on Sphere Flow Diverter Technology Published

We are excited to announce the encouraging results from our flow-diverter device ‘Sphere’, intended to treat cerebral bifurcation aneurysms, have been published!

The paper is published in the latest issue of Cardiovascular Engineering and Technology (CVET), titled  “The ‘Sphere’: A Dedicated Bifurcation Aneurysm Flow-Diverter Device”, and show that the device offers very significant levels of flow reduction in a number of anatomically accurate aneurysm sizes and locations, with many...

Read More

Sphere Flow Diverter Technology Patent Issued in Japan

We are happy to announce that a patent for our Sphere Flow Diverter technology has issued in Japan.

Our disruptive Sphere technology is designed specifically for endovascular treatment of cerebral aneurysms occurring at bifurcations – a condition for which before the development of Sphere there was no acceptable endovascular treatment. The device is spherical in shape and consists of a high density patterned surface constructed from Nitinol® wire which when placed, reduces aneurysm...

Read More

Second Sphere Technology Patent Issued by the United States Patent and Trademark Office

A second patent for our Sphere technology has issued today by The United States Patent and Trademark Office (USPTO).

Our disruptive Sphere technology is designed specifically for endovascular treatment of cerebral aneurysms occurring at bifurcations – a condition for which before the development of Sphere there was no acceptable endovascular treatment. The device is spherical in shape and consists of a high density patterned surface constructed from Nitinol® wire which when placed,...

Read More

Sphere Technology Patent Issued by the United States Patent and Trademark Office

A new patent for our Sphere technology has issued today by The United States Patent and Trademark Office (USPTO).

Our disruptive Sphere technology is designed specifically for endovascular treatment of  cerebral aneurysms occurring at bifurcations – a condition for which before the development of Sphere there was no acceptable endovascular treatment. The device is spherical in shape and consists of a high density patterned surface constructed from Nitinol® wire which when placed,...

Read More

Rectal Prolapse Patent Issued by the United States Patent and Trademark Office

The MINT Program is happy to announce that the United States Patent and Trademark Office (USPTO) has issued a new patent for our Rectal Prolapse project.

The patent issued on April 30, 2013 as US 8,430,890 B2

The innovative rectal prolapse treatment is designed to enable the repair of a prolapsed rectum (rectum leaves the body due to laxity in the pelvic floor muscles) through an endolumenal (internal surface) approach...

Read More